BFO
MRNA icon

Boston Family Office’s Moderna MRNA Stock Holding History

Boston Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Hold
5,315
– – 0.02% 250
2026
Q1 		$270K Buy
+5,315
New +$248K 0.02% 281
2025
Q1 		– Sell
-5,362
Closed -$223K – 283
2024
Q4 		$223K Sell
5,362
-3,980
-43% -$190K 0.02% 259
2024
Q3 		$624K Buy
9,342
+4,258
+84% +$391K 0.04% 184
2024
Q2 		$604K Buy
5,084
+2,741
+117% +$347K 0.04% 180
2024
Q1 		$250K Buy
2,343
+319
+16% +$32.2K 0.02% 237
2023
Q4 		$201K Buy
+2,024
New +$170K 0.02% 253

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Boston Family Office's MRNA Position: Q2 2026 in Review

Boston Family Office held its Moderna (MRNA) position steady in Q2 2026 at 5,315 shares worth $372K. The position accounts for 0.02% of the portfolio, ranked #250.

Boston Family Office first reported a position in MRNA in Q4 2023 and has held it in 7 quarters since. The position peaked at $624K in Q3 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Boston Family Office held 5,315 shares of Moderna worth $372K as of Q2 2026.
  • Boston Family Office left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.02% of Boston Family Office's portfolio in Q2 2026, its #250 holding.
  • Boston Family Office first reported a position in Moderna in Q4 2023 and has held it in 7 quarters since.
  • Boston Family Office's Moderna position peaked at $624K in Q3 2024.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Boston Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.